Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

NCT06577090 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

BIOLOGICAL: Nimacimab injection
BIOLOGICAL: Nimacimab placebo injection
COMBINATION_PRODUCT: semaglutide injection
BIOLOGICAL: Nimacimab 300 mg injection

Sponsor

Skye Bioscience, Inc.